ASBMT News  by unknown
2010 BMT TANDEM MEETINGS
WILL BE FEB. 24-28 IN ORLANDO
The combined 2010 annual meetings
of ASBMT and the Center for
International Blood and Marrow Trans-
plant Research (CIBMTR) will be Feb.
24-28 at the Rosen Shingle Creek Con-
vention Center in Orlando.
Recent advances in the broad field of
cellular therapy and blood and marrow
transplantation will be addressed in ple-
nary sessions, concurrent sessions, oral
abstracts, workshops, poster sessions
and symposia.
The scientific program chair for
ASBMT is Joseph H. Antin, MD, of
Dana-Farber Cancer Institute, Boston,
and the chair for CIBMTR is Jeffrey Szer,
MD, of the Royal Melbourne Hospital,
Melbourne, Australia.
In addition to the five days of scientific
sessions for BMT clinicians and
investigators, there will be eight related
conferences and sessions:
- Clinical Research Professionals/Data
Management (Feb. 23-25)
- BMT CTN Coordinators (Feb. 24)
- Pediatric BMT (Feb.25)
- BMT Center Administrators (Feb. 25-
26)
- BMT Pharmacists (Feb. 26-27)
- Transplant Nursing (Feb. 26-28)
- Medical Directors (Feb. 27)
- Mid-Level Practitioners (Feb 27-28)
The deadline for early registration and
for abstract submission isOct. 15.Online
meeting registration, housing and ab-
stract submission can be accessed at
both the ASBMT Web site, www.asbm-
t.org, and the CIBMTR Web site,




Symposia for the 2010 BMT Tandem
Meetings will have new requirements
and procedures for corporate support.
The purpose is to more completely sepa-
rate the scientific and educational con-
tent from commercial and other
considerations and to comply with
evolving rules and guidelines for con-
tinuing medical education.1140The new procedures will have three
components that address selection of
symposia topics and faculty, deadlines
and participation by medical education
companies.Topics and Faculty
The symposia topics, chairs and
speakers will be determined by
a subcommittee of the BMT Tandem
MeetingsOrganizing Committee. An an-
notated list of the proposed symposia
topics and an application form will be
published on the CIBMTR and ASBMT
Web sites, and will be circulated to
health care companies that might have
an interest in supporting a symposium.Deadlines
Companies interested in supporting
a symposium at the meetings will have
two deadlines. The first will be for com-
panies that wish to select and provide
sole support for a symposium. The sec-
ond deadline will be for companies
interested in shared support of a sympo-
sium.
Approval of applications will be
based, in part, on the date of receipt of
an application. Symposia topics that
are not selected for sole support will
be offered for multiple-company sup-
port.Medical Education Companies
The BMT Tandem Meetings are
designating a single medical education
company as its ‘‘preferred vendor’’
for providing educational needs as-
sessment, planning, execution and
outcomes evaluation. Companies pro-
viding support for a symposium will
be strongly encouraged to work with
the preferred vendor.
According to CIBMTR and ASBMT
leaders, the benefits of the new proce-
dures include:
- A complete separation between
symposia content and financial sup-
port, both in fact and in appearance
- A transparent process for the
development of symposia content
and faculty selection- A uniform approach for symposia de-
sign, planning, execution and out-
comes assessment
- A simplified, more economical pro-
cess for companies wanting to sup-
port symposia
‘‘Over the years the organizers of the
BMT Tandem Meetings have always
strived to have symposia stand on their
own scientific and educational merits,
without consideration of commercial in-
terests,’’said Mary M. Horowitz, MD, MS,
scientific director for the meeting and
for the CIBMTR. ‘‘The new procedures
will strengthen the firewall between
symposium content, faculty selection
and commercial support.
‘‘The symposia topics and chairs will
be selected prior to requests for corpo-
rate support, and the corporations that
fund the symposia will have no role in
the educational content or the selection
of faculty,’’ she said.
ASBMT President Claudio Anasetti,
MD, added: ‘‘We highly value corporate
support and feel that our relationship
with companies over the years has al-
ways been mutually beneficial and free
of undue influence. However, the new
procedures will make the process more
transparent and fully separate content
decisions from financial support.
‘‘We developed these new require-
ments and procedures to be in step
with evolving pharma guidelines,
policies of academic institutions,
recommendations of the Insitute of Med-
icine, and the rules of the Accreditation
Council for Continuing Medical Educa-
tion (ACCME),’’ he said.
CJPMedicalCommunications,adivision
of Carden Jennings Publishing Co., Ltd.,
a medical education company based in
Charlotteville, Va., has been selected as
the preferred vendor for the 2010 BMT
Tandem Meetings. The selection was
based on competitive bidding in which
five companieswere invited to submit pro-
posals. Each company had provided satis-
factory services to the BMT Tandem
Meetings in past years.
Continuing medical education credit
for the BMT Tandem Meetings is pro-
vided by the Medical College of Wiscon-
sin in Milwaukee.
